OMEGCA - Multi-Omics Evaluation of Peritoneal Fluid in Gastroesophageal Cancer
Not Applicable
Recruiting
- Conditions
- Gastroesophageal cancerGastric adenocarcinomaGastroesophageal junction adenocarcinomaCancer - StomachCancer - Oesophageal (gullet)
- Registration Number
- ACTRN12624000451505
- Lead Sponsor
- Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1.All patients greater than 18 years-of-age at time of signing consent
2.Have a histologically confirmed diagnosis of one of the following:
a.Gastric adenocarcinoma
b.Gastroesophageal junction adenocarcinoma
3.Is undergoing staging laparoscopy and peritoneal lavage cytology
4.Provides informed consent
Exclusion Criteria
1.Strictly oesophageal cancer
2.Distant organ disease on CT and PET/CT
3.Non-regional nodal disease on CT and PET/CT
4.Peritoneal carcinomatosis on CT and PET/CT
5.Performance status ECOG greater than or equal to 3
6.Undergoing emergency surgery
7.Non-curative/palliative-intent treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year disease free survival (DFS) determined by review of medical records [ 2-years post diagnosis ]
- Secondary Outcome Measures
Name Time Method